0.95
price down icon1.55%   -0.015
after-market Handel nachbörslich: .95
loading

Chromocell Therapeutics Corp Aktie (CHRO) Neueste Nachrichten

pulisher
May 01, 2025

Channel Therapeutics Faces Financial Uncertainty as Auditors Issue Going Concern Warning - Stock Titan

May 01, 2025
pulisher
Apr 17, 2025

Ligand Pharmaceuticals to Merge Units With Channel Therapeutics to Launch Pelthos Therapeutics - marketscreener.com

Apr 17, 2025
pulisher
Apr 17, 2025

Gold Falls Over 1%; D.R. Horton Posts Downbeat Earnings - Benzinga

Apr 17, 2025
pulisher
Apr 17, 2025

Ligand subsidiaries, Chromocell Therapeutics to merge - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Ligand Subsidiary Pelthos Therapeutics To Combine With Channel Therapeutics - marketscreener.com

Apr 17, 2025
pulisher
Apr 17, 2025

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics - GlobeNewswire Inc.

Apr 17, 2025
pulisher
Mar 03, 2025

Channel Therapeutics Corporation announced that it has received $0.25 million in funding -February 24, 2025 - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Channel Therapeutics secures $325,000 promissory note By Investing.com - Investing.com Australia

Mar 03, 2025
pulisher
Mar 03, 2025

Channel Therapeutics secures $325,000 promissory note - Investing.com India

Mar 03, 2025
pulisher
Feb 28, 2025

New Biotech Stocks at Investorideas.com - Investorideas.com newswire

Feb 28, 2025
pulisher
Jan 21, 2025

Wall Street-Heavily Traded - WDRB

Jan 21, 2025
pulisher
Jan 14, 2025

Biopharma IPOs rebound slightly, as class of 2024 lags with a 29% average decline - BioWorld Online

Jan 14, 2025
pulisher
Dec 20, 2024

Channel Therapeutics Advances Novel Pain Treatment Strategy with NaV1.7 Inhibitor Pipeline - StockTitan

Dec 20, 2024
pulisher
Dec 18, 2024

Channel Therapeutics' Pain Treatment Breakthrough: Novel Nerve Block Outperforms Standard Care in Key Trial - StockTitan

Dec 18, 2024
pulisher
Nov 23, 2024

Chromocell Therapeutics Announces Name Change to Channel Therapeutics Corporation and Provides Therapeutic Program Updates - Defense World

Nov 23, 2024
pulisher
Nov 21, 2024

Chromocell Announces Name Change to 'Channel Therapeutics Corporation” and Provides Therapeutic Program Updates - The Manila Times

Nov 21, 2024
pulisher
Nov 21, 2024

Chromocell changes name to Channel Therapeutics, provides program updates - TipRanks

Nov 21, 2024
pulisher
Nov 21, 2024

Channel Therapeutics Corporation Provides Therapeutic Program Update - Marketscreener.com

Nov 21, 2024
pulisher
Nov 21, 2024

Chromocell Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 - Marketscreener.com

Nov 21, 2024
pulisher
Nov 21, 2024

Certain Warrants of Chromocell Therapeutics Corporation are subject to a Lock-Up Agreement Ending on 16-AUG-2024. - Marketscreener.com

Nov 21, 2024
pulisher
Nov 21, 2024

Chromocell Therapeutics Corporation announces an Equity Buyback for $0.25 million worth of its shares. - Marketscreener.com

Nov 21, 2024
pulisher
Nov 21, 2024

Chromocell Therapeutics Corporation Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain - Marketscreener.com

Nov 21, 2024
pulisher
Nov 21, 2024

Chromocell Therapeutics Corporation announced that it expects to receive $0.75 million in funding - Marketscreener.com

Nov 21, 2024
pulisher
Nov 21, 2024

Chromocell to Present at Sidoti Virtual Investor Conference March 13-14 - Marketscreener.com

Nov 21, 2024
pulisher
Nov 21, 2024

Chromocell Therapeutics Corporation Announces Formal Launch of Eye Pain Treatment Program - Marketscreener.com

Nov 21, 2024
pulisher
Nov 21, 2024

Chromocell Therapeutics Corporation announced that it has received $0.75 million in funding - Marketscreener.com

Nov 21, 2024
pulisher
Nov 19, 2024

Channel Therapeutics finalizes corporate restructuring By Investing.com - Investing.com Canada

Nov 19, 2024
pulisher
Nov 19, 2024

Channel Therapeutics finalizes corporate restructuring - Investing.com

Nov 19, 2024
pulisher
Nov 19, 2024

Channel Therapeutics announces corporate restructuring - Investing.com

Nov 19, 2024
pulisher
Oct 29, 2024

Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain - The Manila Times

Oct 29, 2024
pulisher
Oct 28, 2024

Chromocell to Present at Upcoming Fall Investor Conferences - StockTitan

Oct 28, 2024
pulisher
Oct 25, 2024

Chromocell Therapeutics amends stock repurchase plan - TradingPedia

Oct 25, 2024
pulisher
Oct 24, 2024

Chromocell Announces Amendment to Stock Repurchase Plan | CHRO Stock News - StockTitan

Oct 24, 2024
pulisher
Sep 20, 2024

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing - GlobeNewswire

Sep 20, 2024
pulisher
Sep 17, 2024

Another Delaware Publicly Traded Company Proposes A Nevada Move | Allen Matkins - JD Supra

Sep 17, 2024
pulisher
Sep 16, 2024

Chromocell to Participate in Life Sciences Investor Forum September 19th - Yahoo Finance

Sep 16, 2024
pulisher
Sep 11, 2024

CDMO Benuvia Appoints Terry Novak As New CEO - Pharmaceutical Online

Sep 11, 2024
pulisher
Sep 10, 2024

IPO class of 2024 shows value recovery despite mixed stock performance - BioWorld Online

Sep 10, 2024
pulisher
Aug 07, 2024

Tranche Update on Channel Therapeutics Corporation's Equity Buyback Plan announced on August 7, 2024. - Marketscreener.com

Aug 07, 2024
pulisher
Apr 23, 2024

Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just yet - CNBC

Apr 23, 2024
pulisher
Apr 19, 2024

Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session - TradingView

Apr 19, 2024
pulisher
Apr 09, 2024

Chromocell Issues Letter to Stockholders from Chief Executive Officer - StockTitan

Apr 09, 2024
pulisher
Mar 22, 2024

Chutes & Ladders—Bayer undergoes leadership shake-up - Fierce Biotech

Mar 22, 2024
pulisher
Mar 19, 2024

Are there bright times for biotech IPOs ahead? - European Biotechnology Magazine

Mar 19, 2024
pulisher
Mar 12, 2024

Sidoti Events, LLC's Virtual March Small-Cap Conference - Yahoo Finance

Mar 12, 2024
pulisher
Feb 21, 2024

Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million - Stock Titan

Feb 21, 2024
pulisher
Feb 16, 2024

CHRO Stock Price and Chart — AMEX:CHRO - TradingView

Feb 16, 2024
pulisher
Feb 16, 2024

CHROChannel Therapeutics Corporation Latest Stock News & Market Updates - StockTitan

Feb 16, 2024
pulisher
Oct 16, 2023

CHRO IPO NewsPain relief biotech Chromocell Therapeutics sets terms for $9 million IPO - renaissancecapital.com

Oct 16, 2023
pulisher
Jan 11, 2023

Biotech Venture in the UAE Validated by IPO in the U.S. - PR Newswire

Jan 11, 2023
pulisher
Mar 15, 2021

Tina Garyantes – Feliciano Center For Entrepreneurship And Innovation - Montclair State University

Mar 15, 2021
pulisher
Sep 03, 2020

Stocks Telegraph - Stocks Telegraph

Sep 03, 2020
pulisher
Nov 02, 2019

Nestlé and Chromocell Extend Collaboration to Find Alternatives to Salt - Food Manufacturing

Nov 02, 2019
pulisher
Sep 23, 2018

Improving the Reliability and Utility of Streptozotocin‐Induced Rat Diabetic Model - Wiley Online Library

Sep 23, 2018
pulisher
Jun 27, 2017

Chromocell Announces Initiation of Multiple Ascending Doses Portion of Phase 1 Clinical Trial - PR Newswire

Jun 27, 2017
pulisher
Oct 12, 2016

Chromocell and Astellas Announce FDA Fast Track Designation and First Subject Dosing with Lead Candidate CC8464/ASP1807 for the Management of Neuropathic Pain Associated with iSFN - PR Newswire

Oct 12, 2016
pulisher
Jul 15, 2016

News from Central Jersey's pharma, biotech industries - Central New Jersey News

Jul 15, 2016
pulisher
Sep 30, 2015

Astellas, Chromocell Launch Up-to-$515M+ Pain Drugs Collaboration - Genetic Engineering & Biotechnology News

Sep 30, 2015
$1.06
price up icon 0.95%
$31.31
price up icon 3.40%
$580.95
price up icon 0.82%
$292.90
price up icon 2.57%
$4.64
price up icon 6.67%
$77.49
price up icon 4.82%
Kapitalisierung:     |  Volumen (24h):